Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F G Falkner

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Analytical Biochemistry|November 15, 1996
Specific quantitation of genomic DNA in the femtogram range by amplification of repetitive sequencesM Himmelspach, F Gruber, G Antoine, et al.
Virology|August 3, 2005
The nonreplicating smallpox candidate vaccines defective vaccinia Lister (dVV-L) and modified vaccinia Ankara (MVA) elicit robust long-term protectionS Coulibaly, P Brühl, J Mayrhofer, et al.
Protein Expression and Purification|January 12, 1999
Defective vaccinia virus as a biologically safe tool for the overproduction of recombinant human secretory proteinsM Himly, M Pfleiderer, G Holzer, et al.
Virology|September 19, 1998
Dominant host range selection of vaccinia recombinants by rescue of an essential geneG W Holzer, W Gritschenberger, J A Mayrhofer, et al.
Thrombosis Research|February 25, 2000
Recombinant human factor X: high yield expression and the role of furin in proteolytic maturation in vivo and in vitroM Himmelspach, M Pfleiderer, B E Fischer, et al.
Journal of Virology|July 5, 2002
Immunogenicity and safety of defective vaccinia virus lister: comparison with modified vaccinia virus AnkaraB T Ober, P Brühl, M Schmidt, et al.
Biotechnology and Applied Biochemistry|December 1, 1996
Production of highly homogeneous and structurally intact recombinant von Willebrand factor multimers by furin-mediated propeptide removal in vitroU Schlokat, B E Fischer, S Herlitschka, et al.
Thrombosis and Haemostasis|August 3, 1992
High level expression of active human prothrombin in a vaccinia virus expression systemF G Falkner, P L Turecek, R T MacGillivray, et al.
Journal of Virology|May 11, 1999
Highly efficient induction of protective immunity by a vaccinia virus vector defective in late gene expressionG W Holzer, G Remp, G Antoine, et al.
Journal of Virology|July 11, 1998
Binding of murine leukemia virus Gag polyproteins to KIF4, a microtubule-based motor proteinW Kim, Y Tang, Y Okada, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Analytical Biochemistry|November 15, 1996
Specific quantitation of genomic DNA in the femtogram range by amplification of repetitive sequencesM Himmelspach, F Gruber, G Antoine, et al.
Virology|August 3, 2005
The nonreplicating smallpox candidate vaccines defective vaccinia Lister (dVV-L) and modified vaccinia Ankara (MVA) elicit robust long-term protectionS Coulibaly, P Brühl, J Mayrhofer, et al.
Protein Expression and Purification|January 12, 1999
Defective vaccinia virus as a biologically safe tool for the overproduction of recombinant human secretory proteinsM Himly, M Pfleiderer, G Holzer, et al.
Virology|September 19, 1998
Dominant host range selection of vaccinia recombinants by rescue of an essential geneG W Holzer, W Gritschenberger, J A Mayrhofer, et al.
Thrombosis Research|February 25, 2000
Recombinant human factor X: high yield expression and the role of furin in proteolytic maturation in vivo and in vitroM Himmelspach, M Pfleiderer, B E Fischer, et al.
Journal of Virology|July 5, 2002
Immunogenicity and safety of defective vaccinia virus lister: comparison with modified vaccinia virus AnkaraB T Ober, P Brühl, M Schmidt, et al.
Biotechnology and Applied Biochemistry|December 1, 1996
Production of highly homogeneous and structurally intact recombinant von Willebrand factor multimers by furin-mediated propeptide removal in vitroU Schlokat, B E Fischer, S Herlitschka, et al.
Thrombosis and Haemostasis|August 3, 1992
High level expression of active human prothrombin in a vaccinia virus expression systemF G Falkner, P L Turecek, R T MacGillivray, et al.
Journal of Virology|May 11, 1999
Highly efficient induction of protective immunity by a vaccinia virus vector defective in late gene expressionG W Holzer, G Remp, G Antoine, et al.
Journal of Virology|July 11, 1998
Binding of murine leukemia virus Gag polyproteins to KIF4, a microtubule-based motor proteinW Kim, Y Tang, Y Okada, et al.
Pageof 4